ClinicalTrials.gg
RecruitingNCT07424209IPNOCARDIOUpdated Feb 20, 2026

Hypnotic Communication in Cardiology: A Randomized Controlled Trial

An interventional study of Hypnotic Communication in Psychological Distress, Pain and Anxiety, sponsored by Università degli Studi del Piemonte Orientale Amedeo Avogadro. Recruiting at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-20.

Sponsored by Università degli Studi del Piemonte Orientale Amedeo Avogadro · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Jun 2025, registered Feb 2026).
  • Started Jun 2025; still recruiting 1 year 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
306
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 213 studies in Pain with a site in Italy — 35 open to participants now, 41 under way, 1 of them phase 3. Pain · Italy.

Planned enrollment
20th of 156
306 · median 80
Started
2025
with 9 others
No phase
102 of 213
14 open now
Primary completion
2027-06
later than 34 of 40 live
Registered
199th of 213
by date

Among the 213 studies in Pain with a site in Italy, this one is the 20th largest by planned enrollment of the 156 interventional ones that give a count, is one of 10 that started in 2025, is one of 102 with no phase, reaches primary completion later than 34 of the 40 other live ones, and was the 199th registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

35 of the 213 studies in Pain with a site in Italy are open now. Recruiting first, the newest first:

29 more — sign in →

All 35 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 213 studies in Pain with a site in Italy, or all of them as a file.
02

Study summary

Undergoing medical procedures, especially surgical ones, is a significant source of emotional stress for patients. Emotions like anxiety, fear, anger, and depression often accompany such experiences and can negatively impact clinical outcomes. Preoperative anxiety, in particular, affects nearly half of all surgical patients and can lead to complications such as hemodynamic instability, increased medication needs, and prolonged recovery times.

Managing this emotional distress is therefore a priority. While pharmacological strategies are commonly used, growing attention is being given to non-drug interventions such as music, art, and play therapies. One such technique is hypnotic communication-a method that uses empathetic, suggestion-based language to influence emotional and physical states without formal hypnotic induction. This technique has roots in anesthesiology and has shown promise in reducing pain and anxiety during medical procedures.

The proposed study aims to evaluate the effectiveness of hypnotic communication in reducing emotional distress in patients undergoing elective coronary angiography. This will be done through a randomized controlled trial involving 306 adult patients at the Cardiology Unit of the Ospedale degli Infermi in Biella, Italy.

Participants will be randomly assigned to either an experimental group receiving hypnotic communication alongside standard care, or a control group receiving standard care only. The hypnotic session, delivered by trained nurses, will begin before the procedure and continue until it ends, following a five-phase structure (pre-induction, induction, core, de-induction, and closure).

The primary outcome is the patient's emotional state-specifically stress, anxiety, depression, anger, and need for help-measured before and after the procedure using the Emotion Thermometer Tool. Secondary outcomes include post-procedural pain (measured 15 and 60 minutes after) and patient satisfaction with the communication technique.

The study is designed with a type I error rate of 0.05 and 80% statistical power, and recruitment is expected to last 24 months. Data will be anonymized, securely stored, and analyzed using appropriate statistical methods. Ethical approval and informed consent are integral parts of the protocol.

By investigating the emotional and clinical impact of hypnotic communication, the study hopes to support its integration into routine care practices, offering a simple, safe, and cost-effective method to enhance patient well-being during invasive procedures.

Read the detailed description

INTRODUCTION Undergoing clinical and care procedures is inherently a source of stress for patients. Further, feelings of discomfort, anger, and depression can influence the patient's overall experience, often in association with emotional states such as fear, tension, and nervousness.

Anxiety, for example, is an emotional adaptive response to stimuli perceived by humans as threatening (stressors). In normal conditions, it supports environmental adaptation to avoid or confront danger. However, when the response to the stimulus is excessive and disproportionate, it can become pathological. This reaction may arise in response to trauma-related triggers or specific situations in which not all elements are fully understood. Acute preoperative anxiety may vary depending on patient characteristics, the type of surgery, or other external circumstances. High levels of preoperative anxiety are associated with negative psychological conditions and somatic effects that may impact anesthesia, surgical outcomes, and rehabilitation. Preoperative anxiety is common among surgical patients and has been widely documented in the literature. From an anesthesiological perspective, the relationship between anxiety and sedation effectiveness is inverse. Notable consequences may include increased pharmacological induction requirements, intraoperative hemodynamic instability, higher consumption of analgesics, prolonged anesthetic recovery, higher rates of postoperative pain, increased morbidity and mortality, patient dissatisfaction with hospitalization, and extended length of stay. This highlights how the perioperative pathway can be highly stressful and anxiety-inducing, starting from the preoperative phase.

Another factor influencing the patient's experience and potentially contributing to distress is pain. Despite the clinical, psychological, and cultural factors known to contribute to the onset of post-surgical, chronic, or post-procedural pain, its management remains a challenge and a priority.

This premise emphasizes the need to implement care strategies aimed at limiting negative emotions, with the goal of preventing and minimizing adverse events during surgery and the postoperative recovery. Various studies have documented the positive effects of care interventions in reducing anxiety and pain, such as music therapy, art therapy, or play therapy. Among these, hypnotic communication is also reported in the literature.

Hypnosis is an altered state of consciousness in which psychological and somatic modifications may occur.

Hypnotic communication involves the delivery of suggestions to the patient without formal hypnotic induction, within a relational context characterized by empathy and trust. It is a communication technique that consciously applies neurolinguistic mechanisms related to certain mental functions. The core principle of hypnotic communication is the awareness of the power of words to generate mental imagery, which resonates in the body and induces changes.

One of its earliest uses in healthcare was in anesthesiology, even before the introduction of ether. Over time, it has been employed in surgical preparation to help patients experience less anxiety and pain, resulting in reduced pharmacological needs and improved postoperative recovery. The literature documents the use of hypnotic communication in routine care procedures, such as peripheral venous catheter (PVC) insertion and PICC placement, as well as in cardiology settings prior to invasive procedures, such as transcatheter ablation in atrial fibrillation and S-ICD implantation. The positive impact of hypnotic communication on patients includes both emotional (anxiety) and pain dimensions, leading to reduced use of analgesic-sedative drugs due to the synergistic effect between hypnotic communication and pharmacological therapy. Previous studies have suggested a possible alteration in patients' perception of procedural duration. Importantly, hypnotic communication has not been found to compromise procedural safety or success rates. A potential limitation in the implementation of hypnotic techniques may be patients' individual predisposition to hypnosis, which can be influenced by personality traits-e.g., highly controlled behaviors may hinder rapport with the operator.

While the positive aspects of hypnotic communication are evident, the literature highlights the need for further methodologically rigorous studies to provide additional evidence regarding the safety and efficacy of this method.

OBJECTIVE OF THE STUDY To evaluate the effectiveness of hypnotic communication in reducing emotional distress (stress, anxiety, depression, anger, and need for help) in patients undergoing elective coronary angiography.

METHODS Study Design This is an open-label, randomized controlled trial with a 1:1 allocation ratio.

Study Setting The study, promoted by the University of Eastern Piedmont (UPO) and coordinated by the Health Professions Direction at the Biella Local Health Authority (ASL Biella), will be conducted in the Cardiology Unit of the Ospedale degli Infermi in Ponderano (ASL Biella).

Eligibility Criteria

Inclusion criteria:

  • Adult patients (≥18 years), of both sexes, referred to the Cardiology Unit and scheduled for elective coronary angiography;
  • Ability to read and understand the Italian language.

Exclusion criteria:

  • Cognitive impairment or neurodegenerative disorders that may compromise the ability to provide informed consent;
  • Psychiatric disorders, neurodegenerative diseases, or major depressive states.

Intervention

Experimental Group In addition to standard care, a session of hypnotic communication will be initiated prior to the coronary angiography.

The intervention will be delivered by nursing staff trained and experienced in hypnotic communication.

The session will begin at the patient's bedside and continue throughout the entire procedure, concluding upon its completion.

Hypnotic communication follows a process consisting of five distinct phases:

  1. Pre-induction
  2. Induction
  3. Core (Body)
  4. De-induction
  5. Closure (Tail)

The session will be discontinued if the patient withdraws consent or reports discomfort at any point.

Control Group Patients in the control group will receive standard of care only. OUTCOMES

Primary Outcome:

Emotional state (stress, anxiety, depression, anger, and need for help), assessed using the Italian version of the Emotion Thermometer Tool, a tool previously used in Italian clinical settings.

This is a visual-analogue scale that evaluates the combination of five emotional dimensions:

  • Stress
  • Anxiety
  • Depression
  • Anger
  • Need help Each dimension is scored on a scale from 0 to 10, where 0 indicates "not at all" and 10 indicates "extremely." For individual items, scores from 0 to 3 are considered low, while scores from 4 to 10 are considered high.

As for the total score of the scale, a score between 9 and 14 is considered mild, 15 to 20 is moderate, and scores above 20 are considered severe.

The assessment will be conducted in the patient's room before preparation for the operating room and will be repeated at the end of the cardiologic procedure.

Secondary Outcomes:

  • Pain, assessed with NRS at 15 and 60 minutes post-procedure;
  • Satisfaction with hypnotic communication (experimental group only), assessed using a 0-5 Likert scale.

SAMPLE SIZE Assuming a type I error (α) of 0.05 and a power of 80%, and considering a standard deviation of the change in patients' emotional state between the beginning and the end of the procedure of 11.43 in the group receiving hypnotic communication and 6.56 in the control group, a total of 306 subjects (153 per group) will be required to detect a pre-post intervention difference of 3.

RECRUITMENT Patients will be recruited during hospitalization. The estimated recruitment period is 24 months, assuming a 90% enrollment rate of the patients scheduled weekly for elective coronary angiography.

ALLOCATION Randomization based on a randomization list, will use sealed opaque envelopes. Patients may be withdrawn due to consent withdrawal or significant intraoperative changes.

BLINDING Not applicable (open-label design). DATA COLLECTION, MANAGEMENT, AND ANALYSIS Data will be collected in four phases: enrollment, pre-intervention, intervention, and post-intervention. Outcomes will be analyzed using ITT principles, with appropriate statistical tests and mixed models if needed. Significance will be set at p \< 0.05.

ETHICAL ASPECTS AND DISSEMINATION Ethical approval will be obtained. All data will be anonymized and securely stored. The study will be published regardless of outcomes.

INFORMED CONSENT Obtained by trained nurses through both oral explanation and written documentation. Consent for data processing will also be obtained.

CONFIDENTIALITY Patients will be identified by an alphanumeric code. No personally identifiable information will be recorded.

03

Conditions studied

  • Psychological Distress
  • Pain
  • Anxiety

Keywords

  • Hypnosis
  • Psychological distress
  • Coronary Angiography
  • Pain
  • Anxiety
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients (≥18 years), of both sexes, referred to the Cardiology Unit and scheduled for elective coronary angiography;
  • Ability to read and understand the Italian language.

Exclusion criteria

Exclusion Criteria:

  • Cognitive impairment or neurodegenerative disorders that may compromise the ability to provide ;
  • Psychiatric disorders, neurodegenerative diseases, or major depressive states.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
306 participants (estimated)

Study arms

  • Experimental
    Hypnotic Communication

    In the intervention group, adult patients (≥18 years), of both sexes, referred to the Cardiology Unit and scheduled for elective coronary angiography, who are able to read and understand Italian, will receive a session of hypnotic communication in addition to standard care. This session will be conducted by nursing staff trained in hypnotic communication. It will begin at the patient's bedside before the procedure and continue throughout the coronary angiography, ending when the procedure is complete. The communication technique follows a structured five-phase model: pre-induction, induction, core (body), de-induction, and closure (tail). It uses empathetic, suggestive language without formal hypnosis, aiming to reduce emotional distress (such as anxiety, stress, and fear) and improve the overall patient experience. Patients may withdraw from the session at any time if they feel discomfort or no longer wish to participate.

    Other: Hypnotic Communication

  • No intervention
    Control group

    Patients in the control group will receive standard of care only.

Interventions

  • OtherHypnotic Communication

    Hypnotic communication follows a process consisting of five distinct phases (Granone, 1989): 1. Pre-induction 2. Induction 3. Core (Body) 4. De-induction 5. Closure (Tail) The intervention will be delivered by nursing staff trained and experienced in hypnotic communication. The session will begin at the patient's bedside and continue throughout the entire procedure, concluding upon its completion.

06

What researchers measure

Primary outcomes

  1. Emotional state (stress, anxiety, depression, anger, and need for help), assessed with the Italian version of the Emotion Thermometer Tool

    Emotional state (stress, anxiety, depression, anger, and need for help), assessed using the Italian version of the Emotion Thermometer Tool. This is a visual-analogue scale that evaluates the combination of five emotional dimensions: * Stress * Anxiety * Depression * Anger * Need help Each dimension is scored on a scale from 0 to 10, where 0 indicates "not at all" and 10 indicates "extremely." For individual items, scores from 0 to 3 are considered low, while scores from 4 to 10 are considered high. As for the total score of the scale, a score between 9 and 14 is considered mild, 15 to 20 is moderate, and scores above 20 are considered severe.

    Time frame: Immediately before preparation for transfer to the hemodynamics laboratory and 60 minutes after completion of the coronary angiography procedure.

Secondary outcomes

  1. Pain, assessed with NRS

    Pain will be assessed with NRS at 15 and 60 minutes post-procedure.

    Time frame: At 15 and 60 minutes post-procedure

  2. Level of patient's satisfaction

    Satisfaction with hypnotic communication (experimental group only), assessed using a 0-5 Likert scale.

    Time frame: Within 60 minutes after completion of the coronary angiography procedure.

07

Study locations

1 of 1 sites recruiting
  • Azienda Sanitaria Locale di Biella
    Ponderano, Italy 13875, Italy
    Recruiting
    • Simona Milani, MSN · Contactsimona.milani@aslbi.piemonte.it · 003901515153432
    • Dino Stefano Di Massimo, MSN · Contactdinostefano.dimassimo@aslbi.piemonte.it · 003901515153432
    • Cinzia Rollino, RN · Sub investigator
    • Giuseppina D'Amico, RN · Sub investigator
    • Massimo Fusco, RN · Sub investigator
    • Paolo Giachino, RN · Sub investigator
    • Gaetana Incardona, RN · Sub investigator
    • Cinzia Ravetto, RN · Sub investigator
    • Manuela Tonella, RN · Sub investigator
    • Chiara Gallione, PhD, MSN, RN · Sub investigator
08

References and documents

Publications

  • Scaglione M, Battaglia A, Lamanna A, Cerrato N, Di Donna P, Bertagnin E, Muro M, Alberto Caruzzo C, Gagliardi M, Caponi D. Adjunctive hypnotic communication for analgosedation in subcutaneous implantable cardioverter defibrillator implantation. A prospective single center pilot study. Int J Cardiol Heart Vasc. 2021 Jul 13;35:100839. doi: 10.1016/j.ijcha.2021.100839. eCollection 2021 Aug. PubMed 34307829 ↗
  • Wang R, Huang X, Wang Y, Akbari M. Non-pharmacologic Approaches in Preoperative Anxiety, a Comprehensive Review. Front Public Health. 2022 Apr 11;10:854673. doi: 10.3389/fpubh.2022.854673. eCollection 2022. PubMed 35480569 ↗
  • Scaglione M, Battaglia A, Di Donna P, Peyracchia M, Bolzan B, Mazzucchi P, Muro M, Caponi D. Hypnotic communication for periprocedural analgesia during transcatheter ablation of atrial fibrillation. Int J Cardiol Heart Vasc. 2019 Jul 27;24:100405. doi: 10.1016/j.ijcha.2019.100405. eCollection 2019 Sep. PubMed 31388561 ↗
  • Ruiz Hernandez C, Gomez-Urquiza JL, Pradas-Hernandez L, Vargas Roman K, Suleiman-Martos N, Albendin-Garcia L, Canadas-De la Fuente GA. Effectiveness of nursing interventions for preoperative anxiety in adults: A systematic review with meta-analysis. J Adv Nurs. 2021 Aug;77(8):3274-3285. doi: 10.1111/jan.14827. Epub 2021 Mar 23. PubMed 33755246 ↗
  • Noergaard MW, Hakonsen SJ, Bjerrum M, Pedersen PU. The effectiveness of hypnotic analgesia in the management of procedural pain in minimally invasive procedures: A systematic review and meta-analysis. J Clin Nurs. 2019 Dec;28(23-24):4207-4224. doi: 10.1111/jocn.15025. Epub 2019 Sep 3. PubMed 31410922 ↗
  • Mitchell AJ, Baker-Glenn EA, Granger L, Symonds P. Can the Distress Thermometer be improved by additional mood domains? Part I. Initial validation of the Emotion Thermometers tool. Psychooncology. 2010 Feb;19(2):125-33. doi: 10.1002/pon.1523. PubMed 19296462 ↗
  • Monolo D, Barisone M, Cordio G, Della Sanita M, Airoldi C, Radrizzani D, Bassi E, Dal Molin A, Gallione C. The use of hypnotic communication in PICC placement: randomized controlled trial study. Am J Clin Hypn. 2024 Sep;66(3):249-261. doi: 10.1080/00029157.2023.2258946. Epub 2023 Oct 3. PubMed 37788329 ↗
  • Jones HG, Rizzo RRN, Pulling BW, Braithwaite FA, Grant AR, McAuley JH, Jensen MP, Moseley GL, Rees A, Stanton TR. Adjunctive use of hypnosis for clinical pain: a systematic review and meta-analysis. Pain Rep. 2024 Sep 10;9(5):e1185. doi: 10.1097/PR9.0000000000001185. eCollection 2024 Oct. PubMed 39263007 ↗
  • Hauser W, Hagl M, Schmierer A, Hansen E. The Efficacy, Safety and Applications of Medical Hypnosis. Dtsch Arztebl Int. 2016 Apr 29;113(17):289-96. doi: 10.3238/arztebl.2016.0289. PubMed 27173407 ↗
  • Fusco N, Bernard F, Roelants F, Watremez C, Musellec H, Laviolle B, Beloeil H; Effect of Language and Confusion on Pain During Peripheral Intravenous Catheterization (KTHYPE) group. Hypnosis and communication reduce pain and anxiety in peripheral intravenous cannulation: Effect of Language and Confusion on Pain During Peripheral Intravenous Catheterization (KTHYPE), a multicentre randomised trial. Br J Anaesth. 2020 Mar;124(3):292-298. doi: 10.1016/j.bja.2019.11.020. Epub 2019 Dec 18. PubMed 31862159 ↗
  • Friedrich S, Reis S, Meybohm P, Kranke P. Preoperative anxiety. Curr Opin Anaesthesiol. 2022 Dec 1;35(6):674-678. doi: 10.1097/ACO.0000000000001186. Epub 2022 Sep 21. PubMed 36131642 ↗
  • Granone, F. (1989) Trattato di ipnosi. Torino: UTET.
  • Abate SM, Chekol YA, Basu B. Global prevalence and determinants of preoperative anxiety among surgical patients: A systematic review and meta-analysis. Vol. 25, International Journal of Surgery Open. Elsevier Ltd; 2020. p. 6-16.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2025 (actual). Primary completion is estimated for Jun 2027, 24 months after the start.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 24 months is above that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 6, 2026
First posted
Feb 20, 2026
StartActual
Jun 9, 2025
Primary completionEst.
Jun 9, 2027
CompletionEst.
Oct 9, 2027
Last update
Feb 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07424209
Lead sponsor
Università degli Studi del Piemonte Orientale Amedeo Avogadro
Collaborators
Azienda Sanitaria Locale Biella
Responsible party
Sponsor
First posted
Feb 20, 2026
Start date
Jun 9, 2025
Primary completion
Jun 9, 2027 (estimated)
Completion
Oct 9, 2027 (estimated)
Last update
Feb 20, 2026

Study contacts

Alberto Dal Molin, Associate Professor, PhD
Contact
alberto.dalmolin@med.uniupo.it
+39 0321660607
Dino Stefano Di Massimo, MSN
Contact
dinostefano.dimassimo@aslbi.piemonte.it
01515153432
Simona Milani, MSN
principal investigator · Azienda Sanitaria Locale Biella

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion